normetanephrine and bromocriptine

normetanephrine has been researched along with bromocriptine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Kehr, W	1
Adams, J; Agyin, C; Alatrach, M; Cersosimo, E; Chamarthi, B; Chilton, R; Cincotta, AH; Cominos, N; DeFronzo, RA; Ezrokhi, M; Triplitt, C	1

Other Studies

2 other study(ies) available for normetanephrine and bromocriptine

Article	Year
3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo. Journal of neural transmission, 1981, Volume: 50, Issue:2-4 Topics: 4-Butyrolactone; Animals; Apomorphine; Brain; Bromocriptine; Dextroamphetamine; Dopamine; Kinetics; Lisuride; Male; Mice; Norepinephrine; Normetanephrine; Pargyline; Receptors, Dopamine	1981
Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects. International journal of molecular sciences, 2022, Aug-09, Volume: 23, Issue:16 Topics: Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycogen Synthase Kinase 3 beta; Humans; Interleukin-18; L-Selectin; Leukocytes, Mononuclear; NF-E2-Related Factor 2; NIMA-Interacting Peptidylprolyl Isomerase; NLR Family, Pyrin Domain-Containing 3 Protein; Normetanephrine; Oxidative Stress; Phenotype; Prolactin; RNA, Messenger; Superoxide Dismutase-1; Sympatholytics; Thiobarbituric Acid Reactive Substances; Toll-Like Receptor 2; Toll-Like Receptor 4	2022

Article

Year

3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.

Journal of neural transmission, 1981, Volume: 50, Issue:2-4

Topics: 4-Butyrolactone; Animals; Apomorphine; Brain; Bromocriptine; Dextroamphetamine; Dopamine; Kinetics; Lisuride; Male; Mice; Norepinephrine; Normetanephrine; Pargyline; Receptors, Dopamine

1981

Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.

International journal of molecular sciences, 2022, Aug-09, Volume: 23, Issue:16

Topics: Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycogen Synthase Kinase 3 beta; Humans; Interleukin-18; L-Selectin; Leukocytes, Mononuclear; NF-E2-Related Factor 2; NIMA-Interacting Peptidylprolyl Isomerase; NLR Family, Pyrin Domain-Containing 3 Protein; Normetanephrine; Oxidative Stress; Phenotype; Prolactin; RNA, Messenger; Superoxide Dismutase-1; Sympatholytics; Thiobarbituric Acid Reactive Substances; Toll-Like Receptor 2; Toll-Like Receptor 4

2022